SANDOSTATIN LAR

This brand name is authorized in Australia, Croatia, Cyprus, Estonia, Ireland, Japan, Lithuania, Malta, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug SANDOSTATIN LAR contains one active pharmaceutical ingredient (API):

1	Octreotide UNII 75R0U2568I - OCTREOTIDE ACETATE
	Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system.
	Read more about Octreotide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SANDOSTATIN LAR Powder and solvent for suspension for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01CB02	Octreotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10533J, 10543X, 10549F, 10550G, 10558Q, 10566D, 11501H, 11512X, 11537F, 11893Y, 11894B, 11896D
EE	Ravimiamet	1041309, 1041310, 1041321, 1875359, 1875371, 1875393
GB	Medicines & Healthcare Products Regulatory Agency	41506, 41536, 41539
HR	Agencija za lijekove i medicinske proizvode	HR-H-791598560, HR-H-983646054
IE	Health Products Regulatory Authority	88179, 88180, 88181
JP	医薬品医療機器総合機構	2499403G1021, 2499403G2028, 2499403G3024
LT	Valstybinė vaistų kontrolės tarnyba	1067019, 1067022, 1067024
MT	Medicines Authority	MA1249/00603, MA1249/00604, MA1249/00605
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W42954002, W42954003, W42955002, W42955003, W42956002, W42956003
SG	Health Sciences Authority	11637P, 11638P, 11645P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504770018, 8699504770056, 8699504770100
ZA	Health Products Regulatory Authority	33/34/0239, 33/34/0240, 33/34/0241, 33/34/0242